1. Segmental ¹⁸F-FDG-PET/CT in a single pulmonary nodule: a better cost/effectiveness strategy

   • Marco Spadafora
   • Leonardo Pace
   • Luigi Mansi

   Editorial 03 October 2016 Pages: 1 - 4

2. How to scan who: the delicate balance between selecting the patient and selecting the imaging protocol

   • Roland Hustinx

   Reply 13 September 2016 Pages: 5 - 7

3. [18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches

   • Evelyn E. C. de Jong
   • Wouter van Elmpt
   • Anne-Marie C. Dingemans

   Original Article Open access 06 September 2016 Pages: 8 - 16

   

4. Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235

   • Jose G. Bazan
   • Fenghai Duan
   • Billy W. Loo Jr

   Original Article 19 September 2016 Pages: 17 - 24

   

5. PET/CT-guided percutaneous biopsy of FDG-avid metastatic bone lesions in patients with advanced lung cancer: a safe and effective technique

   • Wei Guo
   • Bing Hao
   • Long Sun

   Original Article Open access 22 July 2016 Pages: 25 - 32

   

6. Pretreatment tumor SUV_max predicts disease-specific and overall survival in patients with head and neck soft tissue sarcoma

   • Seung Cheol Ha
   • Jungsu S. Oh
   • Sang Yoon Kim

   Original Article 23 July 2016 Pages: 33 - 40

   

7. Evaluation of bone-seeking novel radiotracer ⁶⁸Ga-NO2AP-Bisphosphonate for the detection of skeletal metastases in carcinoma breast

   • Averilicia Passah
   • Madhavi Tripathi
   • Chandrasekhar Bal

   Original Article 25 July 2016 Pages: 41 - 49

   

8. Treatment response evaluation with ¹⁸F-FDG PET/CT and ¹⁸F-NaF PET/CT in multiple myeloma patients undergoing high-dose chemotherapy and autologous stem cell transplantation

   • Christos Sachpekidis
   • J. Hillengass
   • A. Dimitrakopoulou-Strauss

   Original Article 29 August 2016 Pages: 50 - 62

   

9. Prognostic impact of tumour burden assessed by metabolic tumour volume on FDG PET/CT in anal canal cancer

   • Mathieu Gauthé
   • Marion Richard-Molard
   • Astrid Lièvre

   Original Article 09 August 2016 Pages: 63 - 70

   

10. The value of ¹⁸F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma

    • Peter S. N. van Rossum
    • David V. Fried
    • Steven H. Lin

    Original Article Open access 11 August 2016 Pages: 71 - 80

    

11. ¹⁷⁷Lu-DKFZ-PSMA-617 therapy in metastatic castration resistant prostate cancer: safety, efficacy, and quality of life assessment

    • Madhav Prasad Yadav
    • Sanjana Ballal
    • Chandrasekhar Bal

    Original Article 10 August 2016 Pages: 81 - 91

    

12. Comparison of ⁶⁸Ga-labelled PSMA-11 and ¹¹C-choline in the detection of prostate cancer metastases by PET/CT

    • Johannes Schwenck
    • Hansjoerg Rempp
    • Christian la Fougère

    Original Article 24 August 2016 Pages: 92 - 101

    

13. Diagnostic potential of PET/CT using a ⁶⁸Ga-labelled prostate-specific membrane antigen ligand in whole-body staging of renal cell carcinoma: initial experience

    • Lino M. Sawicki
    • Christian Buchbender
    • Hubertus Hautzel

    Short Communication 21 March 2016 Pages: 102 - 107

    

14. Editorial: Listen to your belly, fat is not your foe!

    • Jörg Kotzerke
    • Klaus Zöphel

    Editorial Commentary 12 October 2016 Pages: 108 - 109

15. Metabolic and morphological measurements of subcutaneous and visceral fat and their relationship with disease stage and overall survival in newly diagnosed pancreatic adenocarcinoma

    • Christophe Van de Wiele
    • Mathias Van Vlaenderen
    • Alex Maes

    Original Article 11 October 2016 Pages: 110 - 116

    

16. SPECT myocardial blood flow quantitation toward clinical use: a comparative study with ¹³N-Ammonia PET myocardial blood flow quantitation

    • Bailing Hsu
    • Lien-Hsin Hu
    • Tao-Cheng Wu

    Original Article 01 September 2016 Pages: 117 - 128

    

17. Prediction of coronary artery calcium progression by FDG uptake of large arteries in asymptomatic individuals

    • Sang-Geon Cho
    • Ki Seong Park
    • Hee-Seung Bom

    Original Article 28 September 2016 Pages: 129 - 140

    

18. Short-term changes in arterial inflammation predict long-term changes in atherosclerosis progression

    • Philip Joseph
    • Amorina Ishai
    • Ahmed Tawakol

    Original Article 13 October 2016 Pages: 141 - 150

    

19. Characterization of PET/CT images using texture analysis: the past, the present… any future?

    • Mathieu Hatt
    • Florent Tixier
    • Dimitris Visvikis

    Review Article 06 June 2016 Pages: 151 - 165

    

20. ¹⁷⁷Lu-PSMA-617 radioligand therapy of mCRPC: evaluation criteria of response

    • Kambiz Rahbar
    • Martin Bögemann
    • Hojjat Ahmadzadehfar

    Letter to the Editor 04 October 2016 Pages: 166 - 167

21. Reply to Rahbar K et al.

    • Madhav Prasad Yadav
    • Sanjana Ballal
    • Chandrasekhal Bal

    Reply 01 October 2016 Pages: 168 - 169

22. Do paraneoplastic changes in diffuse FDG organ uptake predict relapse? – Wait for confirmation study

    • Regine Kluge
    • Lars Kurch
    • Dirk Hasenclever

    Letter to the Editor 19 October 2016 Pages: 170 - 171

23. Reply

    • Linda Jorgov
    • Françoise Montravers
    • Jean-Noël Talbot

    Reply 11 October 2016 Pages: 172 - 172

24. A rare case of rectal carcinoma and prostate carcinoma with coexistent Paget’s disease mimicking bone metastases in both ¹⁸F-FDG and ⁶⁸Ga PSMA PET/CT

    • Arun Sasikumar
    • Ajith Joy
    • Jayaprakash Madhavan

    Image of the Month 04 October 2016 Pages: 173 - 173

25. EANM Springer Prizes awarded at EANM’ 16 Barcelona

    Society Communications 08 October 2016 Pages: 174 - 175

    

26. Erratum to: Performance of cardiac cadmium-zinc-telluride gamma camera imaging in coronary artery disease: a review from the cardiovascular committee of the European Association of Nuclear Medicine (EANM)

    • Denis Agostini
    • Pierre-Yves Marie
    • on behalf of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM)

    Erratum 07 October 2016 Pages: 176 - 176

27. Erratum to: Characterization of the radiolabeled metabolite of tau PET tracer 18F-THK5351

    • Ryuichi Harada
    • Shozo Furumoto
    • Nobuyuki Okamura

    Erratum 13 October 2016 Pages: 177 - 177